165 related articles for article (PubMed ID: 33316361)
21. High-dose-rate brachytherapy with or without intensity modulated radiation therapy as salvage treatment for an isolated, gross local recurrence of prostate cancer post-prostatectomy.
Strom TJ; Wilder RB; Fernandez DC; Mellon EA; Saini AS; Hunt DC; Biagioli MC
Brachytherapy; 2014; 13(2):123-7. PubMed ID: 24269146
[TBL] [Abstract][Full Text] [Related]
22. Treatment of early-stage prostate cancer among rural and urban patients.
Baldwin LM; Andrilla CH; Porter MP; Rosenblatt RA; Patel S; Doescher MP
Cancer; 2013 Aug; 119(16):3067-75. PubMed ID: 23765584
[TBL] [Abstract][Full Text] [Related]
23. Geographic disparities in residential proximity to colorectal and cervical cancer care providers.
Hung P; Deng S; Zahnd WE; Adams SA; Olatosi B; Crouch EL; Eberth JM
Cancer; 2020 Mar; 126(5):1068-1076. PubMed ID: 31702829
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of treatment for localized prostate cancer in a single institution: comparison of radical prostatectomy and radiation therapy by propensity score matching analysis.
Hayashi N; Osaka K; Muraoka K; Hasumi H; Makiyama K; Kondo K; Nakaigawa N; Yao M; Mukai Y; Sugiura M; Takano S; Ito E; Kaizu H; Koike I; Hata M; Taguri M; Miyoshi Y; Izumi K; Kawahara T; Uemura H
World J Urol; 2020 Oct; 38(10):2477-2484. PubMed ID: 31875247
[TBL] [Abstract][Full Text] [Related]
25. Additional treatments and reimbursement rates associated with prostate cancer treatment for patients undergoing radical prostatectomy, interstitial brachytherapy, and external beam radiotherapy.
Goharderakhshan RZ; Grossfeld GD; Kassis A; Shinohara K; Roach M; Carroll PR
Urology; 2000 Oct; 56(4):622-6. PubMed ID: 11018618
[TBL] [Abstract][Full Text] [Related]
26. Time-driven activity-based cost comparison of prostate cancer brachytherapy and intensity-modulated radiation therapy.
Dutta SW; Bauer-Nilsen K; Sanders JC; Trifiletti DM; Libby B; Lash DH; Lain M; Christodoulou D; Hodge C; Showalter TN
Brachytherapy; 2018; 17(3):556-563. PubMed ID: 29519605
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic Body Radiation Therapy and High-Dose-Rate Brachytherapy Boost in Combination With Intensity Modulated Radiation Therapy for Localized Prostate Cancer: A Single-Institution Propensity Score Matched Analysis.
Chen WC; Li Y; Lazar A; Altun A; Descovich M; Nano T; Ziemer B; Sudhyadhom A; Cunha A; Thomas H; Gottschalk A; Hsu IC; Roach M
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):429-437. PubMed ID: 33385496
[TBL] [Abstract][Full Text] [Related]
28. Photon and Proton Radiation Therapy Utilization in a Population of More Than 100 Million Commercially Insured Patients.
Waddle MR; Sio TT; Van Houten HK; Foote RL; Keole SR; Schild SE; Laack N; Daniels TB; Crown W; Shah ND; Miller RC
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1078-1082. PubMed ID: 28939229
[TBL] [Abstract][Full Text] [Related]
29. Costs and Complications After a Diagnosis of Prostate Cancer Treated With Time-Efficient Modalities: An Analysis of National Medicare Data.
Tang C; Lei X; Smith GL; Pan HY; Hess K; Chen A; Hoffman KE; Chapin BF; Kuban DA; Anscher M; Tina Shih YC; Frank SJ; Smith BD
Pract Radiat Oncol; 2020; 10(4):282-292. PubMed ID: 32298794
[TBL] [Abstract][Full Text] [Related]
30. Role of Geography and Nurse Practitioner Scope-of-Practice in Efforts to Expand Primary Care System Capacity: Health Reform and the Primary Care Workforce.
Graves JA; Mishra P; Dittus RS; Parikh R; Perloff J; Buerhaus PI
Med Care; 2016 Jan; 54(1):81-9. PubMed ID: 26565526
[TBL] [Abstract][Full Text] [Related]
31. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT
Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer.
Vu CC; Blas KG; Lanni TB; Gustafson GS; Krauss DJ
Brachytherapy; 2018; 17(6):852-857. PubMed ID: 30076108
[TBL] [Abstract][Full Text] [Related]
33. Use of stereotactic body radiotherapy for prostate cancer in the United States from 2004 through 2012.
Baker BR; Basak R; Mohiuddin JJ; Chen RC
Cancer; 2016 Jul; 122(14):2234-41. PubMed ID: 27171855
[TBL] [Abstract][Full Text] [Related]
34. Adoption of Radiation Technology Among Privately Insured Nonelderly Patients With Cancer in the United States, 2008 to 2014: A Claims-Based Analysis.
Pan HY; Jiang J; Shih YT; Smith BD
J Am Coll Radiol; 2017 Aug; 14(8):1027-1033.e2. PubMed ID: 28408078
[TBL] [Abstract][Full Text] [Related]
35. Trends and variations in utilization and costs of radiotherapy for prostate cancer: A SEER medicare analysis from 2007 through 2016.
Mukherjee K; Small W; Duszak R
Brachytherapy; 2022; 21(1):12-21. PubMed ID: 34380592
[TBL] [Abstract][Full Text] [Related]
36. Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity.
Yu JB; Soulos PR; Herrin J; Cramer LD; Potosky AL; Roberts KB; Gross CP
J Natl Cancer Inst; 2013 Jan; 105(1):25-32. PubMed ID: 23243199
[TBL] [Abstract][Full Text] [Related]
37. Contemporary prostate cancer radiation therapy in the United States: Patterns of care and compliance with quality measures.
Lee DJ; Barocas DA; Zhao Z; Huang LC; Koyama T; Resnick MJ; Conwill R; McCollum D; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Penson DF; Hoffman KE
Pract Radiat Oncol; 2018; 8(5):307-316. PubMed ID: 30177030
[TBL] [Abstract][Full Text] [Related]
38. Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016.
Beckmann K; Garmo H; Nilsson P; Franck Lissbrant I; Widmark A; Stattin P
Acta Oncol; 2020 May; 59(5):549-557. PubMed ID: 32122185
[No Abstract] [Full Text] [Related]
39. Nationally representative trends and geographic variation in treatment of localized prostate cancer: the Urologic Diseases in America project.
Cary KC; Punnen S; Odisho AY; Litwin MS; Saigal CS; Cooperberg MR;
Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):149-54. PubMed ID: 25667110
[TBL] [Abstract][Full Text] [Related]
40. Reimbursement and use of intensity-modulated radiation therapy for prostate cancer.
Shahinian VB; Kaufman SR; Yan P; Herrel LA; Borza T; Hollenbeck BK
Medicine (Baltimore); 2017 Jun; 96(25):e6929. PubMed ID: 28640073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
